Nationwide Fund Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-21,117
Closed -$84K 699
2017
Q3
$84K Hold
21,117
﹤0.01% 2959
2017
Q2
$68K Buy
+21,117
New +$68K ﹤0.01% 3018
2016
Q3
Sell
-22,578
Closed -$38K 3232
2016
Q2
$38K Hold
22,578
﹤0.01% 3109
2016
Q1
$41K Buy
+22,578
New +$41K ﹤0.01% 3021